NCT07011225View on ClinicalTrials.gov

Effects of Rehabilitation and Supplementation With Hydrolyzed Collagen vs. Whey Protein on the Cardiopulmonary, Renal, Muscular, and Immunohematological Response of COPD Patients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

December 15, 2027

Conditions
Collagen SupplementationWhey ProteinPulmonary RehabilitationCOPD - Chronic Obstructive Pulmonary Disease
Interventions
DIETARY_SUPPLEMENT

Verisol Collagen 2,5 g/day

Patients allocated to this group will consume Verisol Collagen 2,5 g/day for 90 days.

DIETARY_SUPPLEMENT

Peptech Collagen 2,5 g/day

Patients allocated to this group will consume Peptech Collagen 2,5 g/day for 90 days.

DIETARY_SUPPLEMENT

Peptech Collagen 10 g/day

Patients allocated to this group will consume Peptech Collagen 10 g/day for 90 days.

OTHER

Pulmonary rehabilitation with aerobic and resistance training.

Patients enroled in this group will be submitted to Pulmonary rehabilitation with aerobic and resistance training.

DIAGNOSTIC_TEST

Cardiorespiratory test

The patients allocated to this group will be submitted to initial and final evaluations only.

Trial Locations (1)

75083-515

Evangelical University of Goiás, Anápolis

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT07011225 - Effects of Rehabilitation and Supplementation With Hydrolyzed Collagen vs. Whey Protein on the Cardiopulmonary, Renal, Muscular, and Immunohematological Response of COPD Patients | Biotech Hunter | Biotech Hunter